[1]LEWIS S,LUKOVIC J.Neoadjuvant therapy in esophageal cancer[J].Thorac Surg Clin,2022,32(4):447-456.
[2]DOMPER-ARNAL MJ,FERRANDEZ-ARENAS A,LANAS-ARBELOA A.Esophageal cancer:Risk factors,screening and endoscopic treatment in Western and Eastern countries[J].World J Gastroenterol,2015,21(26):7933-7943.
[3]CHEN T,YOU Y,JIANG H,et al.Epithelial-mesenchymal transition(EMT):A biological process in the development,stem cell differentiation,and tumorigenesis[J].J Cell Physiol,2017,232(12):3261-3272.
[4]YEH CF,CHANG YE,LU CY,et al.Expedition to the missing link:Long noncoding RNAs in cardiovascular diseases[J].J Biomed Sci,2020,27(1):48-63.
[5]RAFIEE A,RIAZI-RAD F,HAVASKARY M,et al.Long noncoding RNAs:regulation,function and cancer[J].Biotechnol Genet Eng Rev,2018,34(2):153-180.
[6]KOPP F.Molecular functions and biological roles of long non-coding RNAs in human physiology and disease[J].J Gene Med,2019,21(8):e3104.
[7]ZHANG Y,LI R,DING X,et al.Upregulation of long non-coding RNA SNHG6 promote esophageal squamous cell carcinoma cell malignancy and its diagnostic value[J].Am J Transl Res,2019,11(2):1084-1091.
[8]GHAFFAR M,KHODAHEMMATI S,LI J,et al.Long non-coding RNA LINC01234 regulates proliferation,invasion and apoptosis in esophageal cancer cells[J].J Cancer,2018,9(22):4242-4249.
[9]HU R,BI R,JIANG L,et al.LncRNA TUSC8 suppresses the proliferation and migration of esophageal cancer cells by downregulation of VEGFA[J].J Cancer,2021,12(21):6393-6400.
[10]TIAN W,JIANG C,HUANG Z,et al.Comprehensive analysis of dysregulated lncRNAs,miRNAs and mRNAs with associated ceRNA network in esophageal squamous cell carcinoma[J].Gene,2019,696(1):206-218.
[11]YU D,RUAN X,HUANG J,et al.Comprehensive analysis of competitive endogenous RNAs network,being associated with esophageal squamous cell carcinoma and its MEMrging role in head and neck squamous cell carcinoma[J].Front Oncol,2020,9(1):1474-1488.
[12]ZHENG Q,ZHANG Q,YU X,et al.FENDRR:A pivotal,cancer-related,long non-coding RNA[J].Biomed Pharmacother,2021,137(1):111390-111397.
[13]LI W,LIU J,ZHAO H.Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma[J].Aging(Albany NY),2020,12(2):1512-1526.
[14]GE C,WU S,WANG W,et al.miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway[J].Oncotarget,2015,6(13):10964-10977.
[15]HE Z,WANG X,HUANG C,et al.The FENDRR/miR-214-3P/TET2 axis affects cell malignant activity via RASSF1A methylation in gastric cancer[J].Am J Transl Res,2018,10(10):3211-3223.
[16]LIU J,DU W.LncRNA FENDRR attenuates colon cancer progression by repression of SOX4 protein[J].Onco Targets Ther,2019,12(1):4287-4295.
[17]WU M,LI W,HUANG F,et al.Comprehensive analysis of the expression profiles of long non-coding RNAs with associated ceRNA network involved in the colon cancer staging and progression[J].Sci Rep,2019,9(1):16910-16919.
[18]LIU H,ZHANG Q,LOU Q,et al.Differential analysis of lncRNA,miRNA and mRNA expression profiles and the prognostic value of lncRNA in esophageal cancer[J].Pathol Oncol Res,2020,26(2):1029-1039.
[19]WANG J,JIANG C,LI N,et al.The circEPSTI1/mir-942-5p/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K/Akt/mTOR pathway[J].Cell Death Dis,2020,11(8):682-699.
[20]YANG F,SHAO C,WEI K,et al.miR-942 promotes tumor migration,invasion,and angiogenesis by regulating EMT via BARX2 in non-small-cell lung cancer[J].J Cell Physiol,2019,234(12):23596-23607.
[21]WANG F,FAN M,ZHOU X,et al.A positive feedback loop between TAZ and miR-942-3p modulates proliferation,angiogenesis,epithelial-mesenchymal transition process,glycometabolism and ROS homeostasis in human bladder cancer[J].J Exp Clin Cancer Res,2021,40(1):44-62.
[22]ZHANG Q,ZHU B,QIAN J,et al.miR-942 promotes proliferation and metastasis of hepatocellular carcinoma cells by inhibiting RRM2B[J].Onco Targets Ther,2019,12(1):8367-8378.